CHIKV infection ends in MCP-induced cellular infiltration in the inflamed joints, and bone reduction could be ameliorated by therapy having an MCP-inhibiting drug, bindarit. Taken jointly, our facts reveal a previously undescribed position for MCPs in CHIKV-induced bone loss: one of recruiting monocytes/OC precursors to joint websites and therefore favoring https://cordellk665xiu9.wikimidpoint.com/user